1610 LIMITED
Financial health, per its FY2023 accounts
The accounts state that the charity reported a net expenditure of £885,494 for the year, resulting in a reduction of total reserves from £1,261,258 to £924,764. The trustees confirm that the charity has sufficient reserves to continue trading for at least twelve months, even if its primary contract is not renewed. The financial position is supported by a reversal of a defined benefit pension deficit into a surplus.
What the accounts disclose
“1610 Limited owns 100% of the subsidiary Incedo Limited. The company's principal activity is to carry out trading activities on behalf of 1610 Limited.” — page 33
Structured financials (annual return, FY ending 31/03/2025)
Register events
- Received assets from another charity (11/03/2019)
- Received assets from another charity (30/07/2014)
Trustees
- Alan Peter Rustad
- David Talbut
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £3.3m | £3.6m |
| 31/03/2024 | £3.2m | £3.2m |
| 31/03/2023 | £3.3m | £4.2m |
| 31/03/2022 | £4.4m | £4.2m |
| 31/03/2021 | £3.5m | £3.7m |
Common questions
Is 1610 LIMITED financially healthy?
The accounts state that the charity reported a net expenditure of £885,494 for the year, resulting in a reduction of total reserves from £1,261,258 to £924,764. The trustees confirm that the charity has sufficient reserves to continue trading for at least twelve months, even if its primary contract is not renewed. The financial position is supported by a reversal of a defined benefit pension deficit into a surplus. Its FY2023 accounts were audited by A C Mole.